In NEC monitoring, which imaging and clinical considerations are used to monitor progression in an at-risk neonate?

• A. Single abdominal exam and MRI only; monitor feeds.
• B. Serial abdominal exams, abdominal radiographs to detect pneumatosis intestinalis or portal venous gas, monitor feeds, abdominal girth, and systemic signs such as temperature instability and leukocytosis/leukopenia.
• C. Only monitor temperature; no imaging.
• D. Abdominal ultrasound exclusively; no clinical signs.

Answer: (B)

Monitoring NEC progression in at‑risk neonates hinges on repeated, integrated clinical and radiographic assessment rather than a single study. Serial abdominal exams let you detect increasing distension, tenderness, or changes in bowel sounds that signal worsening. Measuring abdominal girth over time provides a quantitative cue to distension. Regular abdominal radiographs are essential to identify NEC-specific changes such as pneumatosis intestinalis (gas in the bowel wall) or portal venous gas, with continued imaging as the disease evolves and to catch any progression toward perforation (pneumoperitoneum). Tracking feeds—whether they’re being held or advanced as tolerated—helps gauge gastrointestinal function and trajectory. Systemic signs, including temperature instability and shifts in white blood cell counts (leukocytosis or leukopenia), reflect the systemic inflammatory response and severity of illness. Together, these imaging and clinical indicators create a comprehensive picture of progression better than any single measure. While ultrasound can supplement assessment in some contexts, radiographs remain central for monitoring NEC progression; MRI is not practical for routine NICU monitoring.